Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Implexion Pharma Ab |
| Country | Sweden |
| Start Date | Nov 17, 2022 |
| End Date | Dec 31, 2023 |
| Duration | 409 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2022-02166_Vinnova |
Purpose and goal:
The purpose of this project has been to carry out preparatory steps that facilitate Implexion´s path to clinical studies, with objective of increasing the company´s patient understanding, developing a clinical plan, strengthening the organization and preparing for capitalization. The company has made progress in all areas and is now much better equipped to take on the next step towards clinical studies.
Expected results and effects: ** Denna text är maskinöversatt **
The results from the project means, just as expected, that Implexion is now ready for the next stage of development in the company´s progress towards clinical studies. The company now has a better understanding of the patient perspective, the design of remaining studies and requested results from investors and is ready with an organization that is even better suited to take the company forward.
Approach and implementation: ** Denna text är maskinöversatt **
The design and implementation of the project has worked well, but it has taken somewhat longer than what was expected when the application was submitted.
Implexion Pharma Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant